GPT Analysis

Empower Your Investments! Unleash the Potential with Smart Stock Analysis!

United States Hong Kong China Singapore Japan India
Sorting Arrows
Symbol Company Name Rating Recommendation Evaluation from GPT Action Time
AKG Akg Exim Limited None None None

None
AKG Akg Exim Limited None None None

None
AKASH Akash Infra-Projects Limited None None None

None
AKASH Akash Infra-Projects Limited None None None

None
AKASH Akash Infra-Projects Limited None None None

None
AKASH Akash Infra-Projects Limited None None None

None
AJOONI Ajooni Biotech Limited None None None

None
AJOONI Ajooni Biotech Limited None None None

None
AJOONI Ajooni Biotech Limited None None None

None
AJOONI Ajooni Biotech Limited None None None

None
AJMERA Ajmera Realty & Infra India Limited None None None

None
AJMERA Ajmera Realty & Infra India Limited None None None

None
AJMERA Ajmera Realty & Infra India Limited None None None

None
AJMERA Ajmera Realty & Infra India Limited None None None

None
AJANTPHARM Ajanta Pharma Limited 75 Positive Ajanta Pharma Limited is a drug manufacturer specializing in specialty and generic drugs. The company operates in the healthcare sector and has a strong presence in the Indian market. With a trailing PE ratio of 38.83 and a forward PE ratio of 17.94, the stock appears to be trading at a premium compared to its earnings. However, the company has shown consistent earnings growth with a quarterly growth rate of 19.2% and a revenue growth rate of 7.4%. Ajanta Pharma has a strong profit margin of 16.3% and a healthy dividend yield of 0.58%. The stock has a target mean price of 2319.18, indicating potential upside. Considering these factors, Ajanta Pharma seems to be a promising investment option in the pharmaceutical sector.

2023-08-17 12:57:41
AJANTPHARM Ajanta Pharma Limited None None None

None
AJANTPHARM Ajanta Pharma Limited None None None

None
AJANTPHARM Ajanta Pharma Limited None None None

None
AIROLAM Airo Lam limited None None None

None
AIROLAM Airo Lam limited None None None

None